Stonepine Capital Management, LLC Acer Therapeutics Inc. Transaction History

Stonepine Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.18 - $5.86 $23,600 - $117,200	-20,000 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$2.85 - $4.2 $268,398 - $395,535	-94,175 Reduced 82.48%	20,000 $80,000
Q3 2019 Nov 13, 2019	BUY	$1.95 - $3.93 $222,641 - $448,707	114,175 New	114,175 $364,000
Q1 2018 May 14, 2018	SELL	$14.81 - $20.22 $1.48 Million - $2.02 Million	-100,000 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$11.81 - $19.35 $1.18 Million - $1.94 Million	100,000	100,000 $1.39 Million

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.